Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular RiskLD Colantonio, JN Booth III, AP Bress et al. -
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health statusQintar M, Hirai T, Salisbury AC et al.
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesStone NJ, Robinson JG, American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
-
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchCostanzo MR, Ronco C, Abraham WT et al.
-
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art ReviewG Marquis-Gravel, DJ Moliterno, SG Goodman et al.
-
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al.
-
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance DocumentE Spitzer, E Mc Fadden, P Vranckx et al.
-
Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO RegistryJT Saxon, JA Grantham , AC Salisbury et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
